Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs

Pharmacotherapy
D S StreetmanA S Bertino

Abstract

To examine the impact of individualized pharmacokinetic monitoring (IPM) on the development of aminoglycoside-associated nephrotoxicity (AAN). Retrospective case-control study. Two teaching hospitals. Two thousand four hundred five patients who received aminoglycosides. Aminoglycoside therapy dosed by either IPM or physicians' directions. Patients receiving IPM were significantly less likely to develop AAN by both univariate (7.9% vs 13.2%, p=0.02) and multivariate methods (odds ratio 0.42, p=0.002). Female sex was protective against AAN. Age 50 years and above, high initial aminoglycoside trough, long duration of therapy, and concurrent piperacillin, clindamycin, or vancomycin increased risk of AAN. We estimated that IPM decreased AAN costs by $90,995/100 patients. Individualized pharmacokinetic monitoring significantly decreased the frequency of AAN and its associated economic costs.

References

Apr 1, 1976·Journal of Pharmacokinetics and Biopharmaceutics·R J Sawchuk, D E Zaske
Jul 1, 1975·Antimicrobial Agents and Chemotherapy·J G DahlgrenW L Hewitt
Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jun 11, 1991·Clinical Pharmacology and Therapeutics·M E BurtonM R Vasko
Sep 1, 1990·Therapeutic Drug Monitoring·C J DestacheK M Rowley
Jan 1, 1989·Clinical and Experimental Pharmacology & Physiology·W M Bennett
Jun 30, 1986·The American Journal of Medicine·R D Meyer
Dec 1, 1987·Annals of Internal Medicine·J M EisenbergB L Strom
Jun 1, 1986·The Journal of Infectious Diseases·C L SawyersC R Smith
Oct 1, 1972·Computers and Biomedical Research, an International Journal·L B SheinerK L Melmon
Mar 1, 1984·Annals of Internal Medicine·R D MooreP S Lietman
Jan 1, 1984·The Journal of Antimicrobial Chemotherapy·G Kahlmeter, J I Dahlager
May 15, 1980·The New England Journal of Medicine·C R SmithP S Lietman
Nov 1, 1980·Kidney International·G J Kaloyanides, E Pastoriza-Munoz
Jan 1, 1994·Clinical Pharmacokinetics·J S BertinoC J Destache
Jul 1, 1993·Journal of the American Society of Nephrology : JASN·D J LeeheyJ R Lentino
May 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S Bertino, J C Rotschafer
May 1, 1999·Antimicrobial Agents and Chemotherapy·M P Mingeot-Leclercq, P M Tulkens

❮ Previous
Next ❯

Citations

Jun 15, 2011·Antimicrobial Agents and Chemotherapy·Manjunath P PaiJoseph S Bertino
Sep 12, 2002·Pharmacotherapy·Allison Wood WallaceJoseph S Bertino
Nov 16, 2002·Pharmacotherapy·John PapadopoulosDeb S Sherman
Jan 5, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kristine R CrewsJames M Hoffman
Nov 17, 2011·Drugs·Spyridon PagkalisMatthew E Falagas
Mar 19, 2014·Annales pharmaceutiques françaises·C MochC Paillet
Jan 7, 2014·International Journal of Antimicrobial Agents·Kevin J DownesAlexander A Vinks
Apr 3, 2014·Therapeutic Drug Monitoring·Caroline Fonzo-ChristePascal Bonnabry
Mar 20, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alexandre BoyerNicholas Moore
Nov 18, 2005·Current Opinion in Critical Care·Miet SchetzThomas Golper
Jan 25, 2005·Therapeutic Drug Monitoring·D J TouwUNKNOWN Cost-Effectiveness of Therapeutic Drug Monitoring Committee of the International Association for Therapeutic Drug Monitoring
May 15, 2002·Pharmacoepidemiology and Drug Safety
Mar 1, 2012·Kidney International Supplements
Mar 1, 2012·Kidney International Supplements
Nov 6, 2013·Chest·Candice R PreslaskiJason Poston
Oct 28, 2011·Thérapie·Cécile Burgos Leon-DjianPascal Maire
Jun 7, 2011·Hearing Research·Jing XieJochen Schacht
Apr 1, 2003·Intensive Care Medicine·Sandra L KaneJoseph F Dasta
Apr 16, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tamar F BarlamKavita K Trivedi
Mar 10, 2009·The Korean Journal of Internal Medicine·Ju Seop Kang, Min Ho Lee
Jun 3, 2016·Nigerian Journal of Clinical Practice·A A Akinbodewa, O Okunola
Mar 29, 2016·Expert Review of Clinical Pharmacology·Nynke Gl JagerJason A Roberts
Aug 16, 2014·Journal of Pharmacy Practice·Christopher J Destache
Sep 10, 2014·Journal of Pharmacy Practice·Kurt A Wargo, Jonathan D Edwards
Jun 1, 2012·Therapeutic Advances in Drug Safety·Peter PillansTina Patterson
Sep 15, 2010·Journal of Intensive Care Medicine·Elizabeth A RadiganMelissa A Miller
Aug 8, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Matthew S StankowiczDaniel L Brown
Sep 21, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Marie A Chisholm-BurnsJohn Palmer
Feb 24, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·James M HoffmanGlen T Schumock
Mar 18, 2017·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazutaka AonumaUNKNOWN Japanese Circulation Society and the Japanese Society of Therapeutic Drug Monitoring Joint Working Group
Aug 20, 2019·Journal of Pharmacy Practice·Cameron LanierKim Kelly
Aug 23, 2020·Critical Care Medicine·Ishaq LatTricia A Meyer
Sep 19, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Sarah CarlsenMagnus Arpi
Jul 7, 2018·Open Forum Infectious Diseases·William R Truong, Jason Yamaki
Oct 21, 2020·American Journal of Infection Control·Alicia DeRosaKari A Mergenhagen
Oct 1, 2021·European Journal of Hospital Pharmacy. Science and Practice·Saeideh GhaffariMojtaba Mojtahedzadeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society
Tareq M AljbouriAtallah S Abu-Oliem
Computer Methods and Programs in Biomedicine
K R Franck, J S Bertino
The American Journal of Medicine
Carmi BartalYaniv Almog
© 2021 Meta ULC. All rights reserved